Daptomycin Market SWOT Analysis by 2031
Daptomycin, an antibiotic, is used to heal bacterial infections occurring on the skin and underlying tissues and conditions that have entered the bloodstream. Daptomycin is used for complicated infections, including methicillin-resistant Staphylococcus aureus (MRSA) or superbug infections.
MARKET DYNAMICS
Increasing difficult skin and skin structure infections, rising infections in the proper bloodstream, and rising right-sided infective endocarditis are the major factors for market growth. For instance, according to the World Health Organization (WHO) report, in 2021, skin diseases affected almost 900 million people in the world. Out of which, many were associated with changes in the skin, from skin itching to changes in color, feel, and appearance.
MARKET SCOPE
The "Daptomycin Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Daptomycin market with detailed market segmentation by indication, age-group, strength. The daptomycin market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Daptomycin market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The daptomycin market is segmented on the basis of indication, age-group, and strength. Based on indication, the market is segmented as complicated skin structure infections, bacteremia, and others. Based on age-group, the market is segmented as pediatric and adult. Based on strength, market is segmented as 350mg and 500mg.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Daptomycin market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Daptomycin market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Daptomycin market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Daptomycin market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Daptomycin market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Daptomycin market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Daptomycin market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Daptomycin market in these regions.
MARKET PLAYERS
The report covers key developments in the Daptomycin market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Daptomycin market are anticipated to have lucrative growth opportunities in the future with the rising demand for Daptomycin in the global market. Below mentioned is the list of few companies engaged in the daptomycin market.
The report also includes the profiles of key players in Daptomycin market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and indication, age-group, strength offered, financial information of last 3 years, key development in past five years.
- MERCK AND CO.
- PFIZER
- TEVA PHARMACEUTICALS
- MYLAN
- FRESENIUS KABI
- SAGENT PHARMACEUTICALS
- XELLIA
- HISUN
- HENGRUI PHARMA
- HUADONG MEDICINE
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Daptomycin Market - By Indication
1.3.2 Daptomycin Market - By Age-Group
1.3.3 Daptomycin Market - By Strenth
1.3.4 Daptomycin Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DAPTOMYCIN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DAPTOMYCIN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. DAPTOMYCIN MARKET - GLOBAL MARKET ANALYSIS
6.1. DAPTOMYCIN - GLOBAL MARKET OVERVIEW
6.2. DAPTOMYCIN - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. DAPTOMYCIN MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
7.1. OVERVIEW
7.2. INDICATION MARKET FORECASTS AND ANALYSIS
7.3. COMPLICATED SKIN STRUCTURE INFECTIONS
7.3.1. Overview
7.3.2. Complicated Skin Structure Infections Market Forecast and Analysis
7.4. BACTEREMIA
7.4.1. Overview
7.4.2. Bacteremia Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. DAPTOMYCIN MARKET - REVENUE AND FORECASTS TO 2028 - AGE-GROUP
8.1. OVERVIEW
8.2. AGE-GROUP MARKET FORECASTS AND ANALYSIS
8.3. PEDIATRIC
8.3.1. Overview
8.3.2. Pediatric Market Forecast and Analysis
8.4. ADULT
8.4.1. Overview
8.4.2. Adult Market Forecast and Analysis
9. DAPTOMYCIN MARKET - REVENUE AND FORECASTS TO 2028 - STRENTH
9.1. OVERVIEW
9.2. STRENTH MARKET FORECASTS AND ANALYSIS
9.3. 350MG
9.3.1. Overview
9.3.2. 350mg Market Forecast and Analysis
9.4. 500MG
9.4.1. Overview
9.4.2. 500mg Market Forecast and Analysis
10. DAPTOMYCIN MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Daptomycin Market Overview
10.1.2 North America Daptomycin Market Forecasts and Analysis
10.1.3 North America Daptomycin Market Forecasts and Analysis - By Indication
10.1.4 North America Daptomycin Market Forecasts and Analysis - By Age-Group
10.1.5 North America Daptomycin Market Forecasts and Analysis - By Strenth
10.1.6 North America Daptomycin Market Forecasts and Analysis - By Countries
10.1.6.1 United States Daptomycin Market
10.1.6.1.1 United States Daptomycin Market by Indication
10.1.6.1.2 United States Daptomycin Market by Age-Group
10.1.6.1.3 United States Daptomycin Market by Strenth
10.1.6.2 Canada Daptomycin Market
10.1.6.2.1 Canada Daptomycin Market by Indication
10.1.6.2.2 Canada Daptomycin Market by Age-Group
10.1.6.2.3 Canada Daptomycin Market by Strenth
10.1.6.3 Mexico Daptomycin Market
10.1.6.3.1 Mexico Daptomycin Market by Indication
10.1.6.3.2 Mexico Daptomycin Market by Age-Group
10.1.6.3.3 Mexico Daptomycin Market by Strenth
10.2. EUROPE
10.2.1 Europe Daptomycin Market Overview
10.2.2 Europe Daptomycin Market Forecasts and Analysis
10.2.3 Europe Daptomycin Market Forecasts and Analysis - By Indication
10.2.4 Europe Daptomycin Market Forecasts and Analysis - By Age-Group
10.2.5 Europe Daptomycin Market Forecasts and Analysis - By Strenth
10.2.6 Europe Daptomycin Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Daptomycin Market
10.2.6.1.1 Germany Daptomycin Market by Indication
10.2.6.1.2 Germany Daptomycin Market by Age-Group
10.2.6.1.3 Germany Daptomycin Market by Strenth
10.2.6.2 France Daptomycin Market
10.2.6.2.1 France Daptomycin Market by Indication
10.2.6.2.2 France Daptomycin Market by Age-Group
10.2.6.2.3 France Daptomycin Market by Strenth
10.2.6.3 Italy Daptomycin Market
10.2.6.3.1 Italy Daptomycin Market by Indication
10.2.6.3.2 Italy Daptomycin Market by Age-Group
10.2.6.3.3 Italy Daptomycin Market by Strenth
10.2.6.4 Spain Daptomycin Market
10.2.6.4.1 Spain Daptomycin Market by Indication
10.2.6.4.2 Spain Daptomycin Market by Age-Group
10.2.6.4.3 Spain Daptomycin Market by Strenth
10.2.6.5 United Kingdom Daptomycin Market
10.2.6.5.1 United Kingdom Daptomycin Market by Indication
10.2.6.5.2 United Kingdom Daptomycin Market by Age-Group
10.2.6.5.3 United Kingdom Daptomycin Market by Strenth
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Daptomycin Market Overview
10.3.2 Asia-Pacific Daptomycin Market Forecasts and Analysis
10.3.3 Asia-Pacific Daptomycin Market Forecasts and Analysis - By Indication
10.3.4 Asia-Pacific Daptomycin Market Forecasts and Analysis - By Age-Group
10.3.5 Asia-Pacific Daptomycin Market Forecasts and Analysis - By Strenth
10.3.6 Asia-Pacific Daptomycin Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Daptomycin Market
10.3.6.1.1 Australia Daptomycin Market by Indication
10.3.6.1.2 Australia Daptomycin Market by Age-Group
10.3.6.1.3 Australia Daptomycin Market by Strenth
10.3.6.2 China Daptomycin Market
10.3.6.2.1 China Daptomycin Market by Indication
10.3.6.2.2 China Daptomycin Market by Age-Group
10.3.6.2.3 China Daptomycin Market by Strenth
10.3.6.3 India Daptomycin Market
10.3.6.3.1 India Daptomycin Market by Indication
10.3.6.3.2 India Daptomycin Market by Age-Group
10.3.6.3.3 India Daptomycin Market by Strenth
10.3.6.4 Japan Daptomycin Market
10.3.6.4.1 Japan Daptomycin Market by Indication
10.3.6.4.2 Japan Daptomycin Market by Age-Group
10.3.6.4.3 Japan Daptomycin Market by Strenth
10.3.6.5 South Korea Daptomycin Market
10.3.6.5.1 South Korea Daptomycin Market by Indication
10.3.6.5.2 South Korea Daptomycin Market by Age-Group
10.3.6.5.3 South Korea Daptomycin Market by Strenth
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Daptomycin Market Overview
10.4.2 Middle East and Africa Daptomycin Market Forecasts and Analysis
10.4.3 Middle East and Africa Daptomycin Market Forecasts and Analysis - By Indication
10.4.4 Middle East and Africa Daptomycin Market Forecasts and Analysis - By Age-Group
10.4.5 Middle East and Africa Daptomycin Market Forecasts and Analysis - By Strenth
10.4.6 Middle East and Africa Daptomycin Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Daptomycin Market
10.4.6.1.1 South Africa Daptomycin Market by Indication
10.4.6.1.2 South Africa Daptomycin Market by Age-Group
10.4.6.1.3 South Africa Daptomycin Market by Strenth
10.4.6.2 Saudi Arabia Daptomycin Market
10.4.6.2.1 Saudi Arabia Daptomycin Market by Indication
10.4.6.2.2 Saudi Arabia Daptomycin Market by Age-Group
10.4.6.2.3 Saudi Arabia Daptomycin Market by Strenth
10.4.6.3 U.A.E Daptomycin Market
10.4.6.3.1 U.A.E Daptomycin Market by Indication
10.4.6.3.2 U.A.E Daptomycin Market by Age-Group
10.4.6.3.3 U.A.E Daptomycin Market by Strenth
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Daptomycin Market Overview
10.5.2 South and Central America Daptomycin Market Forecasts and Analysis
10.5.3 South and Central America Daptomycin Market Forecasts and Analysis - By Indication
10.5.4 South and Central America Daptomycin Market Forecasts and Analysis - By Age-Group
10.5.5 South and Central America Daptomycin Market Forecasts and Analysis - By Strenth
10.5.6 South and Central America Daptomycin Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Daptomycin Market
10.5.6.1.1 Brazil Daptomycin Market by Indication
10.5.6.1.2 Brazil Daptomycin Market by Age-Group
10.5.6.1.3 Brazil Daptomycin Market by Strenth
10.5.6.2 Argentina Daptomycin Market
10.5.6.2.1 Argentina Daptomycin Market by Indication
10.5.6.2.2 Argentina Daptomycin Market by Age-Group
10.5.6.2.3 Argentina Daptomycin Market by Strenth
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL DAPTOMYCIN MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. DAPTOMYCIN MARKET, KEY COMPANY PROFILES
13.1. MERCK AND CO.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. PFIZER
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. TEVA PHARMACEUTICALS
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. MYLAN
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. FRESENIUS KABI
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. SAGENT PHARMACEUTICALS
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. XELLIA
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. HISUN
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. HENGRUI PHARMA
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. HUADONG MEDICINE
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. MERCK AND CO.
2. PFIZER
3. TEVA PHARMACEUTICALS
4. MYLAN
5. FRESENIUS KABI
6. SAGENT PHARMACEUTICALS
7. XELLIA
8. HISUN
9. HENGRUI PHARMA
10. HUADONG MEDICINE
11. CIPLA
12. BE PHARMACEUTICALS
13. REDDY'S LABORATORIES
14. NICHI-IKO PHARMACEUTICAL
15. NOVO HOLDINGS A/S
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For